Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists create detailed map of colon cells to unlock secrets of disease

NCT ID NCT05195502

First seen Jun 15, 2026 · Last updated Jun 19, 2026 · Updated 1 time

Summary

This completed study took extra biopsies from 40 people already having a colonoscopy to create a detailed map of the cells in the human colon. By analyzing gene activity and DNA structure in individual cells, researchers hope to better understand how colon diseases and type 2 diabetes develop. The study did not test any treatment, but aims to provide a foundation for future research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Bispebjerg University Hospital

    Copenhagen, 2720, Denmark

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this detailed map of colon cells could help researchers understand how colon diseases and diabetes develop, pointing toward new treatment targets.

What could go wrong

This is a basic science study with no direct treatment. The findings may not lead to any practical medical advances for years, if at all.

Conditions

The condition(s) this trial relates to.

Colonic Neoplasms Diabetes Mellitus Inflammatory Bowel Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.